
NGOtiate is a Danish consultancy house
We are a rare hybrid and a pioneer in our field
About us
NGOtiate is a Danish consultancy house founded in 2007. We are a rare hybrid and a pioneer in our field:
We specialize in enabling non-profit patient associations and pharma companies around the world to make a bigger impact through strategic partnerships. We design related strategies, frameworks and initiatives.
We spark first-in-class and best-in-class innovation partnerships and outcomes for patients. We connect the right people at the right time. We apply data and evidence-based methodologies to uncover untapped potentials and generate new knowledge.
We think and act beyond ‘unmet medical needs’ in our mission to play our part in paving way for solutions that resolve unmet patient needs.
We pay it forward. Our commitment goes beyond our business. We offer free support to individuals looking to establish non-profit patient or family networks in underrepresented disease areas. We’re here to empower the voices that need to be heard the most.
Our value offer
be the change
Helping patient organizations, advocacy groups and digital patient communities
Strategic Patient Engagement (SPE): We are here to help pharma companies build, advance and master it
From building the right strategy and framework, to creating partnerships that move the needle and drive outcome and impact.
Build SPE Understanding, Capabilities, and Frameworks We guide you in developing the operational infrastructure and expertise needed to deliver impactful SPE—from core principles to practical implementation and measurable success.
Tailored SPE Strategies and Methodologies That Drive Impact and Outcome
Whether you’re focusing on enterprise-wide inItiatives, portfolio goals, or asset-specific programs, we’ll help you design SPE strategies and apply validated methodologies that fuel success across R&D, business development, regulatory submissions and launches.
Connecting You with the Right Patient Partners
Applying the right patient partnerships at the right time across your value chain is key. We help you find and collaborate with the perfect individuals and organizations across your Reseach, Development, Regulatory, Business Development and New Product Planning and execution .
Ongoing, Expert Support—24/7
We’re always here to back you up, offering expert advice and hands-on support whenever you need it. Let’s elevate your organization’s approach to SPE, align it with your goals, and set you up for long-term success. Together, we’ll make SPE a driving force behind your R&D and commercial leadership.
HOW WE ARE DIFFERENT
the partnering paradigm
Our laser-focus is on the white space and opportunities that exist in the intersection between unmet medical needs and unmet patient needs.
We are experts in the uncovery of related data and evidence, and in translating this into support of innovation, development and delivery of first-in-class and best-in-class solutions for patients.
We have 20+ years experience in driving change as former employees of pharma and/or patient organizations. We also have extensive experience in start-ups.
We are visionary doers. We are second-to-none partners.
The value of STRATEGIC PATIENT ENGAGEMENT
- Optimizing performance across value chain and ultimately end-user products (ref 1,6)
- Positive effect (e.g. financial effect) on clinical trial recruitment and retention (ref 2,3,4)
- Opportunity for researchers to learn from patients as disease experience experts (ref 6)
- Challenge the set way of thinking – often leading to improved research design, delivery, and dissemination (ref 6)
- Wider impacts of a changed innovation, research culture and agenda (ref 5)
Sources:
1: Wicks P, Richards T, Denegri S, Godlee F. Patients’ roles and rights in research.
2: Crocker Joanna C, Ricci-Cabello Ignacio, Parker Adwoa, Hirst Jennifer A, Chant Alan, Petit-Zeman Sophie et al. Impact of patient and public involvement on enrolment and retention in clinical trials: systematic review and meta-analysis
3: Boivin Antoine, Richards Tessa, Forsythe Laura, Grégoire Alexandre, Esperance Audrey, Abelson Julia et al. Evaluating patient and public involvement in research.
4: Levitan, Getz et al. 2018: Assessing the Financial Value of Patient Engagement 5 Staley, K. “Researchers don’t know what they’re missing”—the impact of patient involvement in research
6: Vat et. al (2019) Evaluating the “return on patient engagement initiatives” in medicines research and development
leadership team


